nach oben

Inflammopharmacology

Erschienen in:

28.02.2019 | Review

Syk: a new target for attenuation of Helicobacter pylori-induced gastric mucosal inflammatory responses

verfasst von: Bronislaw L. Slomiany, Amalia Slomiany

Erschienen in: Inflammopharmacology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

The magnitude of gastric mucosal inflammatory response to H. pylori relies primarily on the extent of its key endotoxin, LPS, engagement of Toll-like receptor-4 (TLR4) and the initiation of signal transduction events converging on mitogen-activated protein kinase (MAPK) and IκB complex (IKK) cascades. These cascades, in turn, exert their control over the assembly of transcription factors, NFκB and AP1, implicated in the induction of the expression of iNOS and COX-2 proinflammatory genes. The LPS-induced TLR4 activation and the ensuing phosphorylation of its intracellular tyrosine domain by Src-family kinases not only leads to recruitment to the cytoplasmic domain of TLR4 of adaptor molecules directly involved in propagation of the signaling cascades converging on MAPK and IKK, but also provides a propitious docking site for a non-receptor tyrosine kinase, spleen tyrosine kinase (Syk), the activation of which apparently leads to upregulation in the expression of proinflammatory genes. Here, we review the pathways engaged by H. pylori in the recruitment and interaction of Syk with TLR4 in gastric mucosa, and discuss the cascades involved in Syk-mediated amplification in proinflammatory signaling. We focus, moreover, on the potential role of drugs targeting Syk and TLR4 in the treatment of H. pylori-related gastric disease.

Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801CrossRefPubMed

Amith SR, Abdulkhalek S, Szewczuk MR (2016) Role of glycosylation in toll-like receptor activation and pro-inflammatory responses. In: Weiderschain G (ed) Glycobiology and human diseases. CRC, Boca Raton, pp 165–184CrossRef

Ayala G, Escobedo-Hinojosa WI, Cruz-Herrera CF, Romero I (2014) Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol 20:1450–1469CrossRefPubMedPubMedCentral

Backert S, Neumann M (2010) What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 18:479–486CrossRefPubMed

Barochia A, Slomon S, Cui X, Natanson C, Eichacker PQ (2011) Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies. Expert Opin Drug Metab Toxicol 7:479–494CrossRefPubMedPubMedCentral

Barukcic I (2017) Helicobacter pylori—the cause of human cancer. J Biosci Med 5:1–9

Bauer B, Meyer TF (2011) The human gastric pathogen Helicobacter pylori and its association with gastric cancer and ulcer disease. Ulcers 2011 (Article ID 340157). https://doi.org/10.1155/2011/340157

Beutler B, Jiang Z, Georgel P et al (2006) Gen etic analysis of host resistance: toll-like receptor signaling and immunity at large. Ann Rev Immunol 24:353–389CrossRef

Bhat NR, Feinstein DL, Shen O, Bhat AN (2002) p38 MAPK-mediated transcriptional activation of inducible nitric oxide synthase in glial cells. Roles of nuclear factors, nuclear factor κB, cAMP response element-binding protein, CCAAT/enhancer-binding protein-β, and activating transcription factor-2. J Biol Chem 277:29584–29592CrossRefPubMed

Bijli KM, Fazal F, Minhajuddin M, Rahman A (2008) Activation of Syk by protein kinase C-d regulates thrombin-induced intracellular adhesion molecule-1 expression in endothelial cells via tyrosine phosphorylation on RelA/p65. J Biol Chem 283:14674–14684CrossRefPubMedPubMedCentral

Bohnenberger H, Oellerich T, Engelke M et al (2011) Complex phosphorylation dynamics control the composition of the Syk interactome in B cells. Eur J Immunol 41:1550–1562CrossRefPubMed

Bryant CE, Quellette A, Lohmann K et al (2007) The cellular Toll-like receptor 4 antagonist E5531 can act as an agonist in horse whole blood. Vet Immunol Immunopathol 116:182–189CrossRefPubMed

Bunnell E, Lynn M, Habet K et al (2000) A lipid A analog, E5531, block the endotoxin response in human volunteers with experimental endotoxemia. Crit Care Med 28:2713–2720CrossRefPubMed

Caivano M, Gorgoni B, Cohen P, Poli V (2001) The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein β(C/EBPβ) and C/EBPδ transcription factors. J Biol Chem 276:48693–48701CrossRefPubMed

Carpenter S, O’Neill LAJ (2009) Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signaling proteins. Biochem J 422:1–10CrossRefPubMed

Chen XZ, Schottker B, Castro FA (2016) Association of Helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: a ten-year follow-up of the ESTHER cohort study. Oncotarget 7:17182–17193PubMedPubMedCentral

Chey WD, Leontiadis GI, Howden CW, Moss SF (2017) ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol 112:212–239CrossRefPubMed

Cho I, Kim SG (2009) A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependnt combinatorial mechanism of gene transrepression by GR. Mol Endocrinol 23:86–99CrossRefPubMedPubMedCentral

Choi SH, Wiesner P, Almazan F, Kim J, Miller YI (2012) Spleen tyrosine kinase regulates AP-1 dependent transcriptional response to minimally oxidized LDL. PLoS One 7:e32378CrossRefPubMedPubMedCentral

Dhar SK, Soni RK, Das BK, Mukhopadhyay G (2003) Molecular mechanism of action of major Helicobacter pylori virulence factors. Mol Cell Biochem 253:207–215CrossRefPubMed

Echizen K, Hirose O, Maeda Y, Ochima M (2016) Inflammation in gastric cancer: interplay of the COX-2/prostaglandin E₂ and Toll-like receptor/MyD88 pathways. Cancer Sci 107:391–397CrossRefPubMedPubMedCentral

Elsori DH, Yakubenko VP, Roome T et al (2011) Protein kinase Cd is acritical component of Dectin-1 signaling in primary human monocytes. J Leukoc Biol 90:599–611CrossRefPubMedPubMedCentral

Endale M, Park SC, Kim S et al (2013) Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology 218:1452–1467CrossRefPubMed

Fallone CA, Chiba N, van Zanten SV et al (2016) The Toronto Consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 151:51–69CrossRefPubMed

Furlong MT, Mahrenholtz AM, Kim KH, Ashendel CL, Harrison ML, Geahlen RL (1997) Identification of the major site of autophosphorylation of the murine protein-tyrosine kinase Syk. Biochim Biophys Acta Mol Cell Res 1355:177–190CrossRef

Garate JA, Stockl J, Fernandez-Alonso MC et al (2015) Anti-endotoxic and structural basis for human MD-2.TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold. Innate Immun 21:490–503CrossRefPubMed

Grishin AV, Wang J, Potoka DA et al (2006) Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J Immunol 176:580–588CrossRefPubMed

Hirota M, Miyazaki S, Minnakuchi T, Takagi T, Shibata H (2002) Myrsinoic Acids B, C and F, anti-inflammatory compounds from Myrsine seguinii. Biosci Biotechnol Biochem 66:655–659CrossRefPubMed

Hossen MJ, Kim SC, Son YJ et al (2015) AP-1 targeting anti-inflammatory activity of the methanolic extract of Persicaria chinensis. Evid Based Complement Altern Med 2015 (Article ID 608126)

Ii M, Matsunaga N, Ket Hazeki et al (2006) A novel cyclohexene derivative, ethyl (6R0-6-[N-(2-chloro-4-fluorophenyl) sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits Toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol Pharmacol 69:1288–1295CrossRefPubMed

Inoue I, Mukoubayashi C, Yoshimura N et al (2011) Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer 129:2704–2711CrossRefPubMed

Jeong D, Yang WS, Yang Y et al (2013) In vitro anti-inflammatory effect of Rhodomyrtus tomentosa methanol extract. J Ethnopharmacol 146:205–213CrossRefPubMed

Jeong D, Yi YS, Sung GH et al (2014) Anti-inflammatory activities and mechanism of Artemisia asiatica. J Ethnopharmacol 152:487–496CrossRefPubMed

Jones KR, Whitmire JM, Merrell S (2010) A tale of two toxins: Helicobacter pylori CagA and VacA modulate host pathways that impact disease. Front Microbiol 1:1–17 (Article 115) CrossRef

Karin M (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483–16486CrossRefPubMed

Kaur M, Singh M, Silakari O (2013) Inhibitors of switch kinase ‘spleen tyrosine kinase’ in inflammation and immune-mediated disorders: a review. Eur J Med Chem 67:434–446CrossRefPubMed

Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, Rokutan K (2001) Type I Helicobacter pylori lipopolysaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 69:4382–4389CrossRefPubMedPubMedCentral

Kawamoto K, Ii M, Kitazaki T, Iizawa Y, Kimura H (2008) TAk-242 selectively suppresses Toll-like receptor 4-signaling mediated by internal domain. Eur J Pharmacol 584:40–48CrossRefPubMed

Kazi JU (2011) The mechanism of protein kinase C regulation. Front Biol 6:328–336

Kim HM, Park BS, Jl Kim et al (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin eritoran. Cell 130:906–917CrossRefPubMed

Kulathu Y, Grothe G, Reth M (2009) Autoinhibition and adapter function of Syk. Immunol Rev 232:286–299CrossRefPubMed

Kusters JG, van Vliet AHM, Kupiers EJ (2006) Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19:449–490CrossRefPubMedPubMedCentral

Liao JC, Deng JS, Chiu CS et al (2012) Anti-inflammatory activities of Cinnamomum cassia constituents in vitro and in vivo. Evid Based Complement Altern Med 201 (Article ID 429320)

Lin YC, Huang DY, Chu CL, Lin WW (2010) Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway. Mol Immunol 47:1569–1578CrossRefPubMed

Lopez-Bergami P, Lau E, Ronai Z (2010) Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 10:65–76CrossRefPubMedPubMedCentral

Miller YI, Choi SH, Weisner P, Bae YS (2012) The SYK side of TLR4: signaling mechanism in response to LPS and minimally oxidized LDL. Br J Pharmacol 167:990–999CrossRefPubMedPubMedCentral

Mullarkey M, Rose JR, Bristol J et al (2003) Inhibition of endotoxin response by E5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharmacol Exp Therapeutics 304:1093–1102CrossRef

Pannee C, Chandhanee I, Wacharee L (2014) Antiinflammatory effects of essential oil from the leaves of Cinnamomum cassia and cinnamaldehyde on lipopolysaccharide-stimulated J774A.1 cells. J Adv Pharm Technol Res 5:164–170CrossRefPubMedPubMedCentral

Paris L, Hu J, Galan J et al (2010) Regulation of Syk by phosphorylation on serine in the linker insert. J Biol Chem 285:3984–39854

Park BS, Lee JO (2013) Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med 45:66. https://doi.org/10.1038/emm.2013.97 CrossRef

Piotrowska H, Kucinska M, Murias M (2012) Biological activity of piceatannol: leaving the shadow of resveratrol. Mutat Res 750:60–82CrossRefPubMed

Piotrowski J (1998) Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents. J Physiol Pharmacol 49:3–24PubMed

Quing Y, Wang M, Lin YM et al (2016) Correlation between Helicobacter pylori-associated gastric disease and colorectal neoplasia. World J Gastroenterol 22:4576–4584CrossRef

Ruggiero P, Rossi G, Tombola F et al (2007) Red wine and green tea reduce H. pylori-or VacA-induced gastritis in a mouse model. World J Gastroenterol 13:349–354CrossRefPubMedPubMedCentral

Shirey KA, Lai W, Scott AJ et al (2013) The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497:498–502CrossRefPubMedPubMedCentral

Slomiany BL, Slomiany A (2006) Cytosolic phospholipase A₂ activation in Helicobacter pylori lipopolysaccharide-induced interference with gastric mucin synthesis. IUBMB Life 58:217–223CrossRefPubMed

Slomiany BL, Slomiany A (2011) Role of ghrelin-induced cSrc activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori. Inflammopharmacology 19:197–204CrossRefPubMed

Slomiany BL, Slomiany A (2013a) Induction in gastric mucosal prostaglandin and nitric oxide by Helicobacter pylori is dependent on MAPK/ERK-mediated activation of IKK-β and cPLA₂: modulatory effect of ghrelin. Inflammopharmacology 21:241–251CrossRefPubMed

Slomiany BL, Slomiany A (2013b) Involvement of p38 MAPK-dependent activator protein (AP-1) activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori to ghrelin. Inflammopharmacology 21:67–78CrossRefPubMed

Slomiany BL, Slomiany A (2014a) Modulation of gastric mucosal inflammatory responses to Helicobacter pylori via ghrelin-induced protein kinase Cδ tyrosine phosphorylation. Inflammopharmacology 22:251–262CrossRefPubMed

Slomiany BL, Slomiany A (2014b) Protein kinase Cδ-mediated posttranslational phosphorylation of constitutive nitric oxide synthase regulates gastric mucosal inflammatory responses to Helicobacter pylori: effect of ghrelin. J Biosci Med 2:20–33

Slomiany BL, Slomiany A (2016) Helicobacter pylori-induced changes in microtubule dynamics conferred by a-tubulin phosphorylation on Ser/Tyr mediate gastric mucosal secretion of matrix metalloproteinase-9 (MMP-9) and its modulation by ghrelin. Inflammopharmacology 24:197–205CrossRefPubMed

Slomiany BL, Slomiany A (2017) Role of LPS-elicited signaling in triggering gastric mucosal inflammatory responses to H. pylori: modulatory effect of ghrelin. Inflammopharmacology 25:415–429CrossRefPubMed

Slomiany BL, Slomiany A (2018a) Role of protein kinase Cδ-mediated spleen tyrosine kinase (Syk) phosphorylation on Ser in the amplification of oral mucosal inflammatory responses to Porphyromonas gingivalis. J Biosci Med 6(3):70–85

Slomiany BL, Slomiany A (2018b) Helicobacter pylori LPS-induced gastric mucosal spleen tyrosine kinase (Syk) recruitment to TLR4 and activation occurs with the involvement of protein kinase Cδ. Inflammopharmacology 26:805–815CrossRefPubMed

Slomiany BL, Slomiany A (2018c) Proinflammatory signaling cascades of periodontopathic oral pathogen Porphyromonas gingivalis. J Biosci Med 6(5):63–88

Slomiany BL, Piotrowski J, Slomiany A (1997) Anti-Helicobacter pylori activities of ebrotidine. Arzneim Forsch Drug Res. 47:475–482

Smith SM (2014) Role of Toll-like receptors in Helicobacter pylori infection and immunity. World J Gastrointest Pathophysiol 5:133–146CrossRefPubMedPubMedCentral

Steimle A, Autenrieth JB, Frick JS (2016) Structure and function: lipid A modifications in commensals and pathogens. Int J Med Microbiol 306:290–301CrossRefPubMed

Surh YJ, Na HK (2016) Therapeutic potential and molecular targets of piceatannol in chronic diseases. Adv Exp Med Biol 928:185–211CrossRefPubMed

Takashima K, Matsunaga N, Yoshimatsu M et al (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on muse sepsis model. Br J Pharmacol 157:1250–1262CrossRefPubMedPubMedCentral

Tombola F, Campello S, De Luca L et al (2003) Plant polyphenols inhibit VacA, a toxin secreted by the gastric pathogen Helicobacter pylori. FEBS Lett 543:184–189CrossRefPubMed

Trent MS, Stead CM, Tran AX, Hankins JV (2006) Diversity of endotoxin and its impact on pathogenesis. J Endotox Res 12:205–223

Venerito M, Krieger T, Ecker T, Leandro G, Malfertheiner P (2013) Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection. Digestion 88:33–45CrossRefPubMed

Wang JG, Aikawa M (2015) Toll-like receptors and Src-family kinases in atherosclerosis—focus on macrophages. Circulation J 79:2332–2334CrossRef

Wittebole X, Castanares-Zapatero D, Laterre PF (2010) Toll-like receptor-4 modulation as a strategy to treat sepsis. Mediat Inflamm 2010 (Article ID 568396)

Yang WS, Lee J, Kim TW et al (2012) Src/NF-kB-targeted inhibition of LPS-induced macrophage activation and dextran sodium sulphate-induced colitis by Archidendron clypearia. J Ethnopharmacol 142:287–293CrossRef

Yang WS, Jeong D, Nam G et al (2013a) AP-1 pathway-targeted inhibition of inflammatory responses in LPS-treated macrophages and EtOH/HCl-treated stomach by Archidendron clyperaria methanol extract. J Ethnopharmacol 146:637–644CrossRefPubMed

Yang WS, Jeong D, Yi YS et al. (2013b) IRAK1/4-targeted anti-inflammatory action of caffeic acid. Mediat Inflamm 2013 (Article ID 518183)

Yang Y, Yu T, Lee YG et al (2013c) Methanol extract of Hopea odorata suppresses inflammatory responses via the direct inhibition of multiple kinases. J Ethnopharmacol 145:598–607CrossRefPubMed

Ye Y, Martinez JD, Perez-Polo RJ, Lin Y, Uretsky BF, Birnbaum Y (2008) The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastin. Am J Physil Heart Circ Physiol 295:H343–H351CrossRef

Yi YS, Son YJ, Ryou C et al (2014) Functional roles of Syk in macrophage-mediated inflammatory responses. Mediat Inflamm 2014 (Article ID 270302)

Yi YS, Cho JY, Kim D (2016) Cerbera manghas methanol extract exerts anti-inflammatory activity by targeting c-Jun N-terminal kinase in the AP-1 pathway. J Ethnopharmacol 193:387–396CrossRefPubMed

Yoon JY, Jeong HY, Kim SH et al (2013) Methanol extract of Evodia lepta displays Syk/Src-targeted anti-inflammatory activity. J Ethnopharmacol 148:999–1007CrossRefPubMed

Titel: Syk: a new target for attenuation of Helicobacter pylori-induced gastric mucosal inflammatory responses
verfasst von: Bronislaw L. Slomiany
Amalia Slomiany
Publikationsdatum: 28.02.2019
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 2/2019
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-019-00577-6

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Anti-inflammatory and antinociceptive properties of the hydroalcoholic fractions from the leaves of Annona crassiflora Mart. in mice

β2-adrenoceptor signaling reduction is involved in the inflammatory response of fibroblast-like synoviocytes from adjuvant-induced arthritic rats

Plantago squarrosa Murray extracts inhibit the growth of some bacterial triggers of autoimmune diseases: GC–MS analysis of an inhibitory extract

Pharmacological and biochemical studies on protective effects of mangiferin and its interaction with nitric oxide (NO) modulators in adjuvant-induced changes in arthritic parameters, inflammatory, and oxidative biomarkers in rats

The effects of coenzyme Q10 supplementation on biomarkers of inflammation and oxidative stress in among coronary artery disease: a systematic review and meta-analysis of randomized controlled trials

Persea americana Mill. crude extract exhibits antinociceptive effect on UVB radiation-induced skin injury in mice